Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Baxter
Merck
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Benzimidazole

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Benzimidazole?

Benzimidazole is an investigational drug.

There have been 12 clinical trials for Benzimidazole. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2013.

The most common disease conditions in clinical trials are Helminthiasis, Parasitic Diseases, and Hemolysis. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Hospital Authority, Hong Kong, and University of Colorado, Denver.

There are three US patents protecting this investigational drug and forty-one international patents.

Recent Clinical Trials for Benzimidazole
TitleSponsorPhase
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric PatientsAlejandro KrolewieckiPhase 2
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceSwiss Tropical & Public Health InstituteN/A
Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceUniversity GhentN/A

See all Benzimidazole clinical trials

Clinical Trial Summary for Benzimidazole

Top disease conditions for Benzimidazole
Top clinical trial sponsors for Benzimidazole

See all Benzimidazole clinical trials

US Patents for Benzimidazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Benzimidazole   Start Trial Heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same Daewoong Pharmaceutical Co., Ltd. (Gyeonggi-do, KR)   Start Trial
Benzimidazole   Start Trial Pyrene derivative, organic light-emitting medium, and organic electroluminescent element containing pyrene derivative or organic light-emitting medium IDEMITSU KOSAN CO., LTD. (Tokyo, JP)   Start Trial
Benzimidazole   Start Trial Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE)   Start Trial
Benzimidazole   Start Trial Composition and method for the deposition of conductive polymers on dielectric substrates   Start Trial
Benzimidazole   Start Trial Multiblock copolymers and methods of use University of Notre Dame du Lac (Notre Dame, IN) Purdue Research Foundation (West Lafayette, IN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Benzimidazole

Drugname Country Document Number Estimated Expiration Related US Patent
Benzimidazole Australia 2016275210 2035-06-08   Start Trial
Benzimidazole Brazil 112017020053 2035-06-08   Start Trial
Benzimidazole Canada 2977752 2035-06-08   Start Trial
Benzimidazole China 107428725 2035-06-08   Start Trial
Benzimidazole European Patent Office 3303320 2035-06-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
AstraZeneca
Moodys
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.